Toward predictive signatures of enzalutamide response and resistance
- PMID: 25151015
- DOI: 10.1016/j.eururo.2014.08.012
Toward predictive signatures of enzalutamide response and resistance
Comment on
-
Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.Eur Urol. 2015 Jan;67(1):53-60. doi: 10.1016/j.eururo.2014.05.005. Epub 2014 May 29. Eur Urol. 2015. PMID: 24882673 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical